Aegerion Pharmaceuticals Inc (NASDAQ:AEGR)

18.59
Delayed Data
As of Jul 02
 -0.24 / -1.27%
Today’s Change
17.73
Today|||52-Week Range
36.68
-11.22%
Year-to-Date

Stock Price Forecast

The 6 analysts offering 12-month price forecasts for Aegerion Pharmaceuticals Inc have a median target of 25.50, with a high estimate of 38.00 and a low estimate of 24.00. The median estimate represents a +37.17% increase from the last price of 18.59.

Analyst Recommendations

The current consensus among 8 polled investment analysts is to Hold stock in Aegerion Pharmaceuticals Inc. This rating has held steady since June, when it was unchanged from a Hold rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.36
Sales
$56.8M
Reporting Date
Jul 28

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 34.29%
 
 
 
 
 
 
Growthannually -8.04%
 
 
 
 
 
 

Sales

Growthquarterly -4.35%
 
 
 
 
 
 
Growthannually 43.77%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.

To view my watchlist

Not a member yet?

Sign up now for a free account